Published in Vaccine on November 24, 2014
Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates. Virulence (2015) 0.86
Aggregatibacter actinomycetemcomitans cytolethal distending toxin activates the NLRP3 inflammasome in human macrophages, leading to the release of proinflammatory cytokines. Infect Immun (2015) 0.76
Vault Nanoparticles: Chemical Modifications for Imaging and Enhanced Delivery. ACS Nano (2016) 0.75
Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature (2006) 24.43
Cryopyrin activates the inflammasome in response to toxins and ATP. Nature (2006) 18.74
NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity (2004) 13.55
The inflammasomes: guardians of the body. Annu Rev Immunol (2009) 12.89
Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity (2006) 10.58
The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol (2008) 10.39
A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem (1997) 9.97
Non-canonical inflammasome activation targets caspase-11. Nature (2011) 8.85
The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity (2009) 6.37
Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis (1992) 5.19
The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol (2010) 4.26
Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ (2006) 4.16
The inflammasome: first line of the immune response to cell stress. Cell (2006) 3.73
Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun (1995) 3.68
Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect Immun (1988) 3.55
Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis (2010) 3.15
The drug resistance-related protein LRP is the human major vault protein. Nat Med (1995) 2.78
Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity (2008) 2.67
Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun (2000) 2.53
A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J Immunol (2009) 2.29
Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun (1997) 2.26
The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol (1999) 2.14
Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J Immunol (2009) 2.09
Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J Cell Biol (1986) 1.98
Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells. Infect Immun (2001) 1.61
Assembly of vault-like particles in insect cells expressing only the major vault protein. J Biol Chem (2001) 1.54
PTEN associates with the vault particles in HeLa cells. J Biol Chem (2002) 1.45
The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J Biol Chem (2004) 1.42
Vaults and the major vault protein: novel roles in signal pathway regulation and immunity. Cell Mol Life Sci (2009) 1.39
Role of gamma interferon in controlling murine chlamydial genital tract infection. Infect Immun (1999) 1.30
Host resistance to lung infection mediated by major vault protein in epithelial cells. Science (2007) 1.30
The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior. Biochemistry (2006) 1.22
The infecting dose of Chlamydia muridarum modulates the innate immune response and ascending infection. Infect Immun (2004) 1.20
Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer. Curr Opin Oncol (2000) 1.16
Alarmins, inflammasomes and immunity. Biomed J (2013) 1.13
Targeting vault nanoparticles to specific cell surface receptors. ACS Nano (2009) 1.13
The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals. J Cell Sci (2006) 1.12
Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells. Cancer Res (2005) 1.12
A vault nanoparticle vaccine induces protective mucosal immunity. PLoS One (2009) 1.07
Anthrax and the inflammasome. Microbes Infect (2011) 1.06
Activated dectin-1 localizes to lipid raft microdomains for signaling and activation of phagocytosis and cytokine production in dendritic cells. J Biol Chem (2009) 1.02
Control of innate and adaptive immunity by the inflammasome. Microbes Infect (2012) 0.97
Human vault-associated non-coding RNAs bind to mitoxantrone, a chemotherapeutic compound. Nucleic Acids Res (2005) 0.94
Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis (2005) 0.93
Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signalling. FEBS J (2006) 0.90
Innate immune responses to Chlamydia pneumoniae infection: role of TLRs, NLRs, and the inflammasome. Microbes Infect (2012) 0.89
Development of a Chlamydia trachomatis T cell Vaccine. Hum Vaccin (2010) 0.87
Laparoscopic study on the microbiology and severity of acute pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol (1994) 0.87
Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges. Infect Drug Resist (2011) 0.86
The La RNA-binding protein interacts with the vault RNA and is a vault-associated protein. J Biol Chem (2002) 0.86
Bioengineered vaults: self-assembling protein shell-lipophilic core nanoparticles for drug delivery. ACS Nano (2014) 0.84
Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice. PLoS One (2012) 0.81